Management tracks: Corvus, Maverick

Precision oncology company Corvus Pharmaceuticals Inc. (NASDAQ:CRVS) hired Mehrdad Mobasher as VP and CMO. He was a group medical director and the venetoclax development lead at the Genentech Inc. unit of Roche (SIX:ROG; OTCQX:RHHBY).

Maverick Therapeutics Inc. (Brisbane, Calif.) promoted Robert DuBridge to EVP, Research and CTO from SVP of research discovery. The T cell therapy company also promoted Chad May to SVP of R&D from VP of R&D. Both positions are newly created...